Health
Biotech Review Accelerates Amid GLP-1 Pill Controversy
Europe is accelerating its review of RevMed’s drug Kailera due to concerns over its GLP-1 pill. The FDA has also cleared Vera's autoimmune therapy.
Coverage timeline — 2 articles
STAT News
Kailera's GLP-1 pill data raises concerns, FDA clears Vera autoimmune therapy, and more biotech news from The Readout
2026-07-08 14:24 UTC
Variety
Jason Brenek has been named as Fathom Entertainment’s new CEO following the previously announced retirement of Ray Nutt. Speaking on behalf of the Fathom Entertainment Board of Directors, Adam Rymer, Chief Commercial Officer at Regal Global Entertainment, said, “Jason is the right leader to bu
2026-07-08 14:33 UTC